Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera (ET/PV)

This study has suspended participant recruitment.
(Investigational New Drug (IND) application for imetelstat has been placed on full clinical hold)
Sponsor:
Information provided by (Responsible Party):
Geron Corporation
ClinicalTrials.gov Identifier:
NCT01243073
First received: November 11, 2010
Last updated: March 24, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: January 2016
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)